BERLIN & GENEVA--(BUSINESS WIRE)--BIOTRONIK SE & Co. KG, a leading manu-facturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies and Endosense, a Swiss medical technology company today announced that they have entered into an exclusive distribution agreement for Endosense’s force-sensing ablation catheter, the TactiCath®. Under the terms of the agreement, BIOTRONIK will be the exclusive distributor of the TactiCath in all major markets outside of the United States, Japan and Asia.
